Timo Minssen

Law Prof.,⚖️🦠🧬🤖💊 @CeBIL_Center Dir.,@uni_copenhagen, @cambridgelaw Affiliate, Advisor @EUofficio, ❤️Blues #AI #Biomed #Data #Regulation #IPR #HealthLaw

[Timo Minssen @TiMinCeBIL]

🔒 New in npj Digital Medicine:
“Quantum cryptography and data protection for medical devices post & pre Q-Day”. By Oscar Freyer, Max Ostermann, Timo Minssen & Stephen Gilbert
👉 https://t.co/knuxHAMORO

#QuantumComputing #Cybersecurity #DigitalHealth #MedTech #Cryptography

[Timo Minssen @TiMinCeBIL]

I’m delighted to share our new empirical ”open access” article:“A #Global #Landscape of #Patenting Activity in #COVID-19 #Vaccines”, freely available here: https://t.co/d0m32nJ164 @CeBIL_Center

[Timo Minssen @TiMinCeBIL]

📢 New in @AmJLMed ! Our article “Statutory Thickets & Drug Shortages: Accumulating Legislation as an Underlying Cause” explores how decades of well-intended laws have unintentionally fueled drug shortages.

🔗 https://t.co/uuyYUzBJT1

#DrugShortages #HealthLaw #PharmaPolicy

[Timo Minssen @TiMinCeBIL]

“IP in Superposition: #Patents, #Trade #Secrets, and #Open #Innovation in #Quantum #Information #Technology”.“

Co-authored with my splendid colleagues Gabriela Lenarczyk & Mateo Aboy, it is now available on SSRN here: https://t.co/3OeAVhm1Jy

[Timo Minssen @TiMinCeBIL]

📢 Delighted about our recent publication in "Expert Review of Medical Devices" on regulatory challenges in multi-country data-driven projects developing & validating #medical #AI systems with E.Niemiec, P.Boland, P.McEntee, @.Cahill & myself. Available @: https://t.co/8yb3qGq8V9

[Microsoft Research @MSFTResearch]

In “AI Testing & Evaluation,” professors Daniel Carpenter & Timo Minssen explore pharma & medical device regulation, including the role of clinical trials, while Microsoft’s Chad Atalla shares where AI governance stakeholders might find inspiration. https://t.co/veOh7psOSg

[Michael Sinha @DrSinhaEsq]

In Geneva this week for the IP Researchers Europe #IPRE conference! Looking forward to presenting early progress on a new project with @TiMinCeBIL @CeBIL_Center @UCPH_Research titled "Novel Diagnostics, Vaccines, and Therapeutics for Pandemics: A Call for Proportionality"

[CeBIL @CeBIL_Center]

Join Prof. @WNicholsonPrice on 19 June (11:00–12:00) for a seminar on Governance mechanisms, acceptability, and trust in medical AI
📍UCPH + Zoom
More info & Registration: https://t.co/wIHxLQSmc7
🔔 Limited seats on-site!
@TiMinCeBIL @UCPH_Research @novonordiskfond @MarceloCorCom

[CeBIL @CeBIL_Center]

AMR is an environmental issue too. We're kicking off #EarthDay with a new EP of #UnpackingAMR ft. @IsaacWeldon & Ilaria Natalia, exploring the socio-ecological dynamics of #AMR and shifting the narrative from a war on microbes to coexistence. Listen here: https://t.co/sZwLNRYS7y

[Petrie-Flom Center @PetrieFlom]

We are five posts into a special digital symposium about artificial intelligence in medicine. Edited by @TiMinCeBIL & @MarceloCorCom at @UCPH_Research, supported by a generous scientifically independent grant from the @novonordiskfond: https://t.co/rs4BGoMP3W

[CLASSICA @classicaproject]

🏥 We are proud to announce the successful launch of CLASSICA-OR at @Beaumont_Dublin! Prof John Burke and his team performed the first surgery using our #AI for real-time #ColorectalCancer classification in situ

🔗 Read more https://t.co/PbeRUdpQ2v
🎥 Hear from @MaterSurgery 👇

[CLASSICA @classicaproject]

🚨 The EU AI Act is now in effect, bringing the world’s first comprehensive AI regulation—with major implications for U.S. health care & medical AI. 🏥🤖

A new @classicaproject @NEJM_AI article by Dr Sebastian Porsdam Mann, Prof. I. Glenn Cohen, & Prof. @TiMinCeBIL Minssen explores:

🔹 AIA’s risk-based approach
🔹 Global reach & impact on U.S. AI developers
🔹 Key provisions supporting AI innovation in medicine
U.S. health care leaders must adapt now to stay competitive. How will this reshape medical AI? Join the discussion! ⬇️ https://t.co/3HaS5uJgQX
#EUAIAct #MedicalAI #AIRegulation #Innovation

[CLASSICA @classicaproject]

🚨 Join us at the Life Sciences AI Summit!

📅 26 March 2025 | Brussels
⚡ "CLASSICA Case Study: Bringing AI Into the Surgery Room: Medical, Ethical, and Legal Challenges" organised by @TiMinCeBIL & @gerke_sara

🔗 Register https://t.co/9YYGAxM5cU

#HorizonEU #LifeSciencesAI

[CLASSICA @classicaproject]

📚 Knowledge Unwrapped: Understanding "Guidelines for ethical use and acknowledgement of large language models in academic writing" by
Sebastian Porsdam Mann @CeBIL_Center et al

🤝 Practical guidance for acknowledging LLMs in academic writing https://t.co/aeJT8x3Zox

#HorizonEU

[Timo Minssen @TiMinCeBIL]

Check out our Inter-@CeBIL_Center Digital Symposium at @Harvard_Law ’s / @PetrieFlom’s Bill of Health blog , edited by Marcelo Corrales Compagnucci and myself. You can follow it here:

https://t.co/ekQoCRQW8L

[CeBIL @CeBIL_Center]

@TiMinCeBIL, Director of CeBIL, has joined the Editorial Board of the @JIPLP -Journal of Intellectual Property Law & Practice (Oxford University Press).
📖 Read more: https://t.co/cML8AdvAnM
--
#IntellectualProperty #IPLaw #AcademicPublishing #CeBIL #JIPLP #OxfordUniversityPress

[Timo Minssen @TiMinCeBIL]

So excited about our papers published this week:

#1 in @NatureMedicine: #Data Sharing in #Precision #Medicine: https://t.co/7JNvSelslf

#2 in @npjDigitalMed: #ASLMs in #ClinicalTrials: https://t.co/iPRZCCB88M

#3 in @AnnalsofSurgery: #AI uses in #Surgery https://t.co/y9uwH0SS6j

[Timo Minssen @TiMinCeBIL]

Delighted to see our collaborative @bioethics_net (AJOB) Target Article led by @casparbarnes123 & Sebastian Porsdam Mann et al. published. The full article: “Enabling Demonstrated Consent for Biobanking with Blockchain and Generative AI” is available here: https://t.co/f9VSlyJbuv

[CTS-FGV @CTS_FGV]

📌 Confira o cronograma detalhado do workshop "Algorithmic Dreams Meet Competition Law and Regulation: Promoting Responsible Innovation"!

[CTS-FGV @CTS_FGV]

Session 2: Digital Health: Competition Law, Regulation, Innovation policy

@JusTechne, @TiMinCeBIL, @IoannisLianos, @Elibietti, Marina Siqueira